268 related articles for article (PubMed ID: 20199662)
1. Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform.
Sabbir MG; Wigle N; Loewen S; Gu Y; Buse C; Hicks GG; Mowat MR
BMC Biol; 2010 Mar; 8():17. PubMed ID: 20199662
[TBL] [Abstract][Full Text] [Related]
2. The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancer.
Sabbir MG; Prieditis H; Ravinsky E; Mowat MR
PLoS One; 2012; 7(7):e40302. PubMed ID: 22792269
[TBL] [Abstract][Full Text] [Related]
3. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
[TBL] [Abstract][Full Text] [Related]
4. DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development.
Durkin ME; Avner MR; Huh CG; Yuan BZ; Thorgeirsson SS; Popescu NC
FEBS Lett; 2005 Feb; 579(5):1191-6. PubMed ID: 15710412
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of the DLC‑1 gene and its inhibitory effect on human colon cancer.
Dai Z; Jin Y
Oncol Rep; 2013 Sep; 30(3):1511-7. PubMed ID: 23783552
[TBL] [Abstract][Full Text] [Related]
6. A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors.
Low JS; Tao Q; Ng KM; Goh HK; Shu XS; Woo WL; Ambinder RF; Srivastava G; Shamay M; Chan AT; Popescu NC; Hsieh WS
Oncogene; 2011 Apr; 30(16):1923-35. PubMed ID: 21217778
[TBL] [Abstract][Full Text] [Related]
7. The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.
Basak P; Dillon R; Leslie H; Raouf A; Mowat MR
BMC Cancer; 2015 Sep; 15():630. PubMed ID: 26353792
[TBL] [Abstract][Full Text] [Related]
8. Nuclear-targeted deleted in liver cancer 1 (DLC1) is less efficient in exerting its tumor suppressive activity both in vitro and in vivo.
Chan LK; Ko FC; Sze KM; Ng IO; Yam JW
PLoS One; 2011; 6(9):e25547. PubMed ID: 21966542
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of DLC1 in endothelial cells compromises the angiogenesis process.
Shih YP; Yuan SY; Lo SH
Cancer Lett; 2017 Jul; 398():46-51. PubMed ID: 28408355
[TBL] [Abstract][Full Text] [Related]
10. Deleted in liver cancer 1 isoforms are distinctly expressed in human tissues, functionally different and under differential transcriptional regulation in hepatocellular carcinoma.
Ko FC; Yeung YS; Wong CM; Chan LK; Poon RT; Ng IO; Yam JW
Liver Int; 2010 Jan; 30(1):139-48. PubMed ID: 19874489
[TBL] [Abstract][Full Text] [Related]
11. H2O2 inhibits proliferation and mediates suppression of migration via DLC1/RhoA signaling in cancer cells.
Ma L; Zhu WZ; Liu TT; Fu HL; Liu ZJ; Yang BW; Song TY; Li GR
Asian Pac J Cancer Prev; 2015; 16(4):1637-42. PubMed ID: 25743845
[TBL] [Abstract][Full Text] [Related]
12. DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway.
Ullmannova-Benson V; Guan M; Zhou X; Tripathi V; Yang XY; Zimonjic DB; Popescu NC
Leukemia; 2009 Feb; 23(2):383-90. PubMed ID: 18923442
[TBL] [Abstract][Full Text] [Related]
13. Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.
Tripathi BK; Grant T; Qian X; Zhou M; Mertins P; Wang D; Papageorge AG; Tarasov SG; Hunter KW; Carr SA; Lowy DR
J Cell Biol; 2017 Dec; 216(12):4255-4270. PubMed ID: 29114068
[TBL] [Abstract][Full Text] [Related]
14. Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
Li G; Du X; Vass WC; Papageorge AG; Lowy DR; Qian X
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17129-34. PubMed ID: 21969587
[TBL] [Abstract][Full Text] [Related]
15. Uncovering the rare variants of DLC1 isoform 1 and their functional effects in a Chinese sporadic congenital heart disease cohort.
Lin B; Wang Y; Wang Z; Tan H; Kong X; Shu Y; Zhang Y; Huang Y; Zhu Y; Xu H; Wang Z; Wang P; Ning G; Kong X; Hu G; Hu L
PLoS One; 2014; 9(2):e90215. PubMed ID: 24587289
[TBL] [Abstract][Full Text] [Related]
16. Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity.
Leung TH; Ching YP; Yam JW; Wong CM; Yau TO; Jin DY; Ng IO
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15207-12. PubMed ID: 16217026
[TBL] [Abstract][Full Text] [Related]
17. Flavone inhibits migration through DLC1/RhoA pathway by decreasing ROS generation in breast cancer cells.
Zhu W; Ma L; Yang B; Zheng Z; Chai R; Liu T; Liu Z; Song T; Li F; Li G
In Vitro Cell Dev Biol Anim; 2016 May; 52(5):589-97. PubMed ID: 26935193
[TBL] [Abstract][Full Text] [Related]
18. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.
Hankins GR; Sasaki T; Lieu AS; Saulle D; Karimi K; Li JZ; Helm GA
Neurosurgery; 2008 Oct; 63(4):771-80; discussion 780-1. PubMed ID: 18981889
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Associated Point Mutations in the
Wang D; Qian X; Sanchez-Solana B; Tripathi BK; Durkin ME; Lowy DR
Cancer Res; 2020 Sep; 80(17):3568-3579. PubMed ID: 32606003
[TBL] [Abstract][Full Text] [Related]
20. DLC1 negatively regulates angiogenesis in a paracrine fashion.
Shih YP; Liao YC; Lin Y; Lo SH
Cancer Res; 2010 Nov; 70(21):8270-5. PubMed ID: 20861185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]